Skip to main content

Table 1 Summary of included trials basic information

From: Effectiveness of acupuncture for angina pectoris: a systematic review of randomized controlled trials

Study ID Settings Recruit Sources TG (M/F) CG (M/F) Age (mean or range) Disease history (mean or range) Diagnostic criteria (angina type) AE
BALLEGAARD 1986 [35] Denmark NR 12/1 11/2 TG: 54; CG: 58 NR Modified WHO/ISFC (SAP) NO
BALLEGAARD 1990 [36] Denmark News 19/5 19/6 TG: 67; CG: 66 NR Modified WHO/ISFC (SAP) NO
CAO JP 2002 [41] MC In 7/23 5/16 TG: 63; CG: 63 TG: 55.14 m; CG: 61.62 m WHO/ISFC, IM 4th (UAP) NR
CHANG PF 2005 [42] MC Out 19/11 17/5 TG: 59; CG: 61 TG:6.4y; CG:7.2y WHO/ISFC, PIM (SAP) NR
DIAO LH 2006 [43] MC NR 8/22 6/24 TG: 57; CG: 57 NR WHO/ISFC, GCC, PIM (SAP) NR
MC NR 9/21 6/24 TG: 57; CG: 57 NR NR
HU NK 1997 [44] MC In 60 60 59 NR WHO/ISFC (CHD-AP) NR
HUANG J 2004 [45] MC Out 22/18 21/19 TG:56; CG:57 TG: 5.3y; CG: 5.2y WHO/ISFC (SAP) NO
HUANG J2 2004 [46] MC Out/In 11/9 7/13 TG: 60; CG: 59 NR WHO/ISFC, PIM (SAP) NR
MC Out/In 7/13 7/13 TG: 60; CG: 59 NR NR
LI CP 2005 [47] MC Out/In 36 34 64 3.82y WHO/ISFC (CHD-AP) NR
LI HJ 2003 [48] MC NR 19/17 16/13 TG: 57; CG: 55 TG: 8y; CG: 7.5y WHO/ISFC (CHD-AP) NR
LIU JL 2007 [49] MC In 20/10 21/9 TG: 57; CG: 57 TG: 9.2y; CG: 8.5y GCC (UAP) NR
LIU JR 2010 [50] MC Out/In 18/12 19/13 TG: 49; CG: 49 TG: 6.6y; CG: 6.5y GCC (CHD-AP) NR
LIU WP 2004 [51] MC In 26/6 25/5 TG: 58; CG: 57 TG: 24.8 m CG: 24.5 m WHO/ISFC (UAP) NR
LIU WP 2003 [52] MC Out/In 19/13 19/12 TG: 58; CG: NR TG: 24.8 m; CG: 20.6 m WHO/ISFC (SAP) NR
LIU YF 2012 [53] MC Out/In 18/15 17/16 TG: 66; CG: 65 6 m-15y 2007ACC/AHA (SAP) NR
TONG YH 2005 [54] MC In 42/38 37/23 TG: 61; CG: 60 TG: 2 m-3.5y; CG: 3 m-3y WHO/ISFC (CHD-AP) NR
WANG PJ 2011 [55] MC In 30 30 53 2-10y Modified GCC (SAP) NR
MC In 30 30 53 2-10y NR
WANG X 2000 [56] MC NR 18/10 14/7 TG: 57; CG: 53 NR WHO/ISFC (UAP) NR
WU CY 2009 [57] MC Out/In 39/29 40/28 TG: 48; CG: 48 TG: 26.4 m; CG: 25.6 m WHO/ISFC (CHD-AP) NR
WU HH 2005 [58] MC In 23/17 19/21 NR NR WHO/ISFC (CHD-AP) NR
XIE ZQ 2003 [59] MC In 15/16 26/10 TG: 61; CG: 60 NR Modified GCC (UAP) NR
XU GD 2006 [60], TONG YH1 2005 [61] MC In 68/52 47/33 TG: 63; CG: 63 TG: 23 m; CG: 2.4 m WHO/ISFC (CHD-AP) NR
YU W 2006 [62] MC In 17/13 15/15 TG: 67; CG: 66 TG: 8.35y; CG: 8.71y WHO/ISFC (CHD-AP) NO
ZHANG L 2011 [63] MC NR 19/16 17/13 TG: 62; CG: 61 TG: 6.70y; CG: 6.52y WHO/ISFC (CHD-AP) NR
ZHANG LJ 2005 [64] MC Out/In 18/22 25/15 TG: 43–70; CG: 43-69 TG: 5 m-20y; CG:2 m-19y. WHO/ISFC, GCC (CHD-AP) NR
MC Out/In 21/19 25/15 TG: 45–72; CG: 43-69 TG: 6 m-24y;CG: 2 m-19y. NR
  1. TG, Treatment Group; CG, Control Group; d, day; m, month; y, year; AE, Adverse Event; Out, outpatient; In, inpatient; News, newspaper; NR, No Report; WHO/ISFC, Nomenclature and criteria for diagnosis of ischemic heart disease; IM Xth, Internal Medicine book (Xth version); PIM, Practice of Internal Medicine book; GCC, Government criteria in China (Guidelines for clinical research of traditional Chinese medicine and new medicine and the other 3 National Conferences’ Advice); CHD, coronary heart disease; AP, angina pectoris; SAP, stable angina pectoris; UAP, unstable angina pectoris; MC, Mainland China.